Orphan Designation's Impact on Share Price
Post# of 30025
Posted On: 10/07/2014 5:04:57 PM
I'm curious about what might happen if AMBS is able to get 1-2 orphan applications approved in the near term.
I found an article written by Jason Napodano that explored this topic. Interesting read. I'm wondering if GC has been approached by BP with partnership offers that are conditioned on AMBS getting the orphan designation for our MANF indication(s).
Perhaps, this could be the "ace up the sleeve" that significantly catapults our pps so that GC can uplist without a massive RS. Wishful thinking? Maybe, but you never know.
Insert-tag-hereseekingalpha.com/article/1894751-orphan-drug-designations-why-you-should-care
I found an article written by Jason Napodano that explored this topic. Interesting read. I'm wondering if GC has been approached by BP with partnership offers that are conditioned on AMBS getting the orphan designation for our MANF indication(s).
Perhaps, this could be the "ace up the sleeve" that significantly catapults our pps so that GC can uplist without a massive RS. Wishful thinking? Maybe, but you never know.
Insert-tag-hereseekingalpha.com/article/1894751-orphan-drug-designations-why-you-should-care
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼